Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.
No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%.
Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...
Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).
Citius Announces Pre-IND Submission to FDA Under the Coronavirus...
Biotech Stock Review: Mitesco (MITI) $0.03, Report Update
Mitesco to Launch Telehealth Enabled Primary Care Clinic Business with Q4 Rollout Addressing Healthcare Backlog Accentuated by the Second Wave Concerns.
Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.
It Ain't Cheap at $3.5 Billion.It's Near Doubled Since March 20th.But Look at the Growth.Look at the Cash.Don't Look at the Bottom...
TeleHealths’ Screaming Growth in Canada.
"Dialogue says it has also seen a surge of customer interest, with 100 companies subscribing to its annual service in the past...
SEC takes enforcement action against 23 companies for claims relating to COVID-19.
Aint Nothing but a Gangter Party.
Like cryptocurrency and cannabis, the coronavirus pandemic may attract fraudsters keen to profit...
How CoronaVirus Accelerated the Rise of Telemedicine (CNBC). Telehealth.
16 minute video on how hospitals and primary care practices are using it and what it could mean for the future of...
After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits.
MedCityNews
The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics....
Organicell (BPSR) a Triple Since Easter.
Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's.
RELATED: Adding Organicell (BPSR)...
MRSA: Methicillin (antibiotic) Resistant Staphylococcus Aureus.
Antibiotic-resistant staph bacteria can lie hidden on your skin for years!
Staphylococcus aureus (SA) is a bacterium found in...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
